GB201517241D0 - DNA modification - Google Patents

DNA modification

Info

Publication number
GB201517241D0
GB201517241D0 GBGB1517241.4A GB201517241A GB201517241D0 GB 201517241 D0 GB201517241 D0 GB 201517241D0 GB 201517241 A GB201517241 A GB 201517241A GB 201517241 D0 GB201517241 D0 GB 201517241D0
Authority
GB
United Kingdom
Prior art keywords
dna modification
dna
modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1517241.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wageningen Universiteit
Original Assignee
Wageningen Universiteit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wageningen Universiteit filed Critical Wageningen Universiteit
Priority to GBGB1517241.4A priority Critical patent/GB201517241D0/en
Publication of GB201517241D0 publication Critical patent/GB201517241D0/en
Priority to PCT/EP2016/073366 priority patent/WO2017055514A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB1517241.4A 2015-09-30 2015-09-30 DNA modification Ceased GB201517241D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1517241.4A GB201517241D0 (en) 2015-09-30 2015-09-30 DNA modification
PCT/EP2016/073366 WO2017055514A1 (en) 2015-09-30 2016-09-29 Dna modification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1517241.4A GB201517241D0 (en) 2015-09-30 2015-09-30 DNA modification

Publications (1)

Publication Number Publication Date
GB201517241D0 true GB201517241D0 (en) 2015-11-11

Family

ID=54544307

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1517241.4A Ceased GB201517241D0 (en) 2015-09-30 2015-09-30 DNA modification

Country Status (2)

Country Link
GB (1) GB201517241D0 (en)
WO (1) WO2017055514A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201700136D0 (en) 2017-01-05 2017-02-22 British American Tobacco Investments Ltd Aerosol generating device and article
GB201700620D0 (en) 2017-01-13 2017-03-01 British American Tobacco Investments Ltd Aerosol generating device and article
GB201720338D0 (en) 2017-12-06 2018-01-17 British American Tobacco Investments Ltd Component for an aerosol-generating apparatus
US20210357907A1 (en) 2020-05-12 2021-11-18 Deeyook Location Technologies Ltd. System, apparatus, and/or method for providing wireless applications based on locationing solutions
US11228469B1 (en) 2020-07-16 2022-01-18 Deeyook Location Technologies Ltd. Apparatus, system and method for providing locationing multipath mitigation

Also Published As

Publication number Publication date
WO2017055514A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
DK3389557T3 (en) Transseptalt leveringssystem
DK3320033T3 (en) Polyethylenterephthalat-depolymerisering
DK3256579T3 (en) Cysteinprotease
DK3256580T3 (en) Cysteinprotease
DK3298030T3 (en) Anti-cancerfusionspolypeptid
DK3250592T3 (en) Anti-transthyretin-antistoffer
GB201503408D0 (en) Oligonucleotides
DK3373882T3 (en) Patientisolator
DK3284069T3 (en) Pos-terminal
GB201500806D0 (en) Aerosol-gnerating aticle
DK3390996T3 (en) Trykbart tids-temperaturindikatorsystem
DK3380145T3 (en) Injektionsapparat
DK3336185T3 (en) Antistof
GB201504124D0 (en) Oligonucleotides
DK3272750T3 (en) Morphinan-derivat
DK3324768T3 (en) Tørdragt
GB201517241D0 (en) DNA modification
IL257500A (en) Modified cullin1 gene
AU361999S (en) Ballustrade
DK3133099T3 (en) Polymermodificeret polyoldispersion
DK3282866T3 (en) Proteinfibre
DK3250312T3 (en) Urea-metalnitrat-scr-system
DK3294653T3 (en) Justerbar inline-port
DK3242882T3 (en) Cgrp-antagonistpeptider
AU5516P (en) LEP08 Lepidosperma squamatum

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)